Biomotion Sciences Warran... (SLXNW)
0.03
-0.01 (-32.58%)
At close: Jan 02, 2025, 9:00 PM
0.03
-0.40%
After-hours Jan 14, 2025, 05:04 PM EST
undefined% (undefined)
| Bid | 0.03 |
| Market Cap | 3.37M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.05 |
| Volume | 5 |
| Avg. Volume (20D) | 0 |
| Open | 0.03 |
| Previous Close | 0.04 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Beta | undefined |
About SLXNW
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol SLXNW
Website https://silexion.com